Absence of Clinical GVHD and the In Vivo Induction of Regulatory T cells following Facilitating Cell Transplantation

[1]  D. Klatzmann,et al.  Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. , 2003, The Journal of clinical investigation.

[2]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[3]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[4]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[5]  S. Wahl,et al.  TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression. , 2003, Cytokine & growth factor reviews.

[6]  C. Fathman,et al.  Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.

[7]  A. Santoni,et al.  Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery , 2002, European journal of immunology.

[8]  B. Blazar,et al.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.

[9]  W. Strober,et al.  Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.

[10]  D. Matesic,et al.  CD4+CD25+ regulatory cells in acquired MHC tolerance , 2001, Immunological reviews.

[11]  Y. Colson,et al.  Characterization of a newly discovered T-cell receptor β-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment , 2000, Nature Medicine.

[12]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[13]  Maki Ito,et al.  Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  I. Weissman,et al.  CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. , 1999, Immunity.

[15]  M. V. D. van den Brink,et al.  IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. , 1999, The Journal of clinical investigation.

[16]  F. Finkelman,et al.  Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. , 1998, Journal of immunology.

[17]  J. Crawford,et al.  An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.

[18]  M. Andreeff,et al.  Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. , 1995, Blood.

[19]  Simon C Watkins,et al.  Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. , 1994, Blood.

[20]  P. Martin,et al.  Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans , 1993, The Journal of experimental medicine.

[21]  J. Ferrara,et al.  Cytokine dysregulation and acute graft-versus-host disease. , 1992, Blood.

[22]  A. Rimm,et al.  Increasing Utilization of Allogeneic Bone Marrow Transplantation , 1992, Annals of Internal Medicine.

[23]  A. Rimm,et al.  T-cell depletion of HLA-identical transplants in leukemia. , 1991, Blood.

[24]  R. Hoffmann,et al.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .

[25]  J. Sprent,et al.  T cell subsets and graft-versus-host disease. , 1987, Transplantation.

[26]  S. Strober,et al.  Cloned natural suppressor cells prevent lethal graft-vs-host disease. , 1987, Journal of immunology.

[27]  J. Sprent,et al.  Functions of Purified L3T4+ and Lyt‐2+ Cells in vitro and in vivo , 1986, Immunological reviews.

[28]  E. Gleichmann,et al.  Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.- host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes , 1983, The Journal of experimental medicine.

[29]  G. McDonald,et al.  Gastrointestinal graft‐versus‐host disease in man: A clinicopathologic study of the rectal biopsy , 1979, The American journal of surgical pathology.